These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21129503)

  • 1. Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutation.
    Winbo A; Diamant UB; Rydberg A; Persson J; Jensen SM; Stattin EL
    Heart Rhythm; 2011 Apr; 8(4):541-7. PubMed ID: 21129503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.
    Winbo A; Diamant UB; Stattin EL; Jensen SM; Rydberg A
    Circ Cardiovasc Genet; 2009 Dec; 2(6):558-64. PubMed ID: 20031635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden cardiac death, founder populations, and mushrooms: what is the link with gold mines and modifier genes?
    Schwartz PJ
    Heart Rhythm; 2011 Apr; 8(4):548-50. PubMed ID: 21193065
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families.
    Winbo A; Stattin EL; Nordin C; Diamant UB; Persson J; Jensen SM; Rydberg A
    BMC Cardiovasc Disord; 2014 Feb; 14():22. PubMed ID: 24552659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To Modify or Not to Modify: Allele-Specific Effects of 3'UTR-
    Winbo A; Diamant UB; Persson J; Jensen SM; Rydberg A
    J Am Heart Assoc; 2022 Sep; 11(18):e025981. PubMed ID: 36102229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.
    Winbo A; Fosdal I; Lindh M; Diamant UB; Persson J; Wettrell G; Rydberg A
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):806-14. PubMed ID: 26019114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common founder effects of hereditary hemochromatosis, Wilson´s disease, the long QT syndrome and autosomal recessive deafness caused by two novel mutations in the
    Olsson KS; Wålinder O; Jansson U; Wilbe M; Bondeson ML; Stattin EL; Raha-Chowdhury R; Williams R
    Hereditas; 2017; 154():16. PubMed ID: 29270100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?
    Crotti L; Lahtinen AM; Spazzolini C; Mastantuono E; Monti MC; Morassutto C; Parati G; Heradien M; Goosen A; Lichtner P; Meitinger T; Brink PA; Kontula K; Swan H; Schwartz PJ
    Circ Cardiovasc Genet; 2016 Aug; 9(4):330-9. PubMed ID: 27531917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
    Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
    J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a novel recessive KCNQ1 mutation associated with Romano-Ward Long-QT syndrome in two Iranian families.
    Zafari Z; Dalili M; Zeinali S; Saber S; Fazeli Far AF; Akbari MT
    J Electrocardiol; 2017; 50(6):912-918. PubMed ID: 29033053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity.
    Giudicessi JR; Ackerman MJ
    Circ Cardiovasc Genet; 2013 Apr; 6(2):193-200. PubMed ID: 23392653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome.
    Zehelein J; Thomas D; Khalil M; Wimmer AB; Koenen M; Licka M; Wu K; Kiehn J; Brockmeier K; Kreye VA; Karle CA; Katus HA; Ulmer HE; Schoels W
    Biochim Biophys Acta; 2004 Nov; 1690(3):185-92. PubMed ID: 15511625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk indicators in long QT syndrome: does location matter?
    Cerrone M
    Heart Rhythm; 2012 Jun; 9(6):899-900. PubMed ID: 22326657
    [No Abstract]   [Full Text] [Related]  

  • 17. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
    Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
    Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
    Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA haplotype map of river valley populations with hemochromatosis traced through five centuries in Central Sweden.
    Olsson KS; Ritter B; Hansson N; Chowdhury RR
    Eur J Haematol; 2008 Jul; 81(1):36-46. PubMed ID: 18363869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.